Not for Distribution to U.S. Newswire Servicers or For Dissemination in the United States
TORONTO â€” Halo Labs Inc. (â€śHaloâ€ť or the â€śCompanyâ€ť) (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce a collaboration with ilo Vaporâ„˘ (â€śiloâ€ť) to launch LevĂ¤tĂ¤â„˘, an alternative wellness brand focused on utilizing DabTabsâ„˘ technology to create a unique measured dose cannabinoid (â€śCBDâ€ť) consumption solution. LevĂ¤tĂ¤â„˘ CBD dosables are infused with precise percentages of CBD and botanically derived terpenes, allowing consumers to accurately control and measure their CBD consumption. To compliment the experience, the LevĂ¤tĂ¤â„˘ collection will also include a vape pen styled device custom made for DabTabsâ„˘ dosables, which utilizes the DabTabsâ„˘ Go technology developed by ilo.
The volumetric accuracy of LevĂ¤tĂ¤â„˘ CBD dosables ensures that consumers can precisely measure their consumption through accurate dosing, another effort towards helping to standardize dosing in a growing industry.
Halo expects to begin sales of the LevĂ¤tĂ¤â„˘ collection to retailers in October, leveraging its direct sales force in California, Oregon, and Nevada. Halo also intends to increase sales of LevĂ¤tĂ¤ through the online retail marketplaces and by partnering large distributors of cannabis peripherals in the United States and Europe.
â€śConsumers of cannabinoid products are becoming increasingly passionate about the wellness benefits of CBD,â€ť said Michael Lindars, CEO and Co-Founder of ilo. â€śThe ability to merge our flagship product, DabTabsâ„˘ dosables, with CBD is the first of many strategic moves to introduce true, clean vaporization into this developing wellness space. We are excited about working with Halo to expand the reach of our DabTabsâ„˘ technology.â€ť
â€śThe CBD market is becoming a larger focus for us,â€ť said Kiran Sidhu, CEO and Co-Founder of Halo. â€śWe are excited to offer the LevĂ¤tĂ¤â„˘ collection, as we look to strengthen and diversify our revenue base through the sale of innovative CBD products.â€ť
Halo is a cannabis extraction company that develops and manufactures quality cannabis oils and concentrates, which are the fastest growing segments in the cannabis industry. Halo is a global leader in cannabis oil and concentrates, having produced over 4 million grams of oils and concentrates since inception. The Company has expertise across all major cannabis manufacturing processes, leveraging a variety of proprietary processes and products. The forward-thinking company is led by a strong management team with deep industry knowledge and blue-chip experience. The Company is currently operating in California and Oregon, as well as in Nevada with our partner Just Quality, LLC, and in Lesotho with the Bophelo strategic partnership. With a consumer-centric focus, Halo will continue to market innovative, branded, and private label products across multiple product categories.
For further information regarding Halo, see Haloâ€™s disclosure documents on SEDAR at www.sedar.com.
ABOUT Ilo Vaporâ„˘
Founded in 2016, ilo Vaporâ„˘, a division of Iconic Ventures Inc., has been quietly developing groundbreaking new technology for cannabis consumption, engineering innovative products that deliver unparalleled vaporization experiences. ilo Vapor is a Portland, Oregon based technology, brand, and product development company that engineers patent-pending vaporization technology solutions.
Cautionary Note Regarding Forward-Looking Information and Statements
This press release contains certain â€śforward-looking informationâ€ť within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute â€śforward-looking statementsâ€ť within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only Haloâ€™s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of Haloâ€™s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as â€śplansâ€ť, â€śexpectsâ€ť or â€śdoes not expectâ€ť, â€śis expectedâ€ť, â€śbudgetâ€ť, â€śscheduledâ€ť, â€śestimatesâ€ť, â€śforecastsâ€ť, â€śintendsâ€ť, â€śanticipatesâ€ť or â€śdoes not anticipateâ€ť, or â€śbelievesâ€ť, or variations of such words and phrases or may contain statements that certain actions, events or results â€śmayâ€ť, â€ścouldâ€ť, â€śwouldâ€ť, â€śmightâ€ť or â€świll be takenâ€ť, â€świll continueâ€ť, â€świll occurâ€ť or â€świll be achievedâ€ť. The forward-looking information and forward-looking statements contained herein may include, but is not limited to, Haloâ€™s launch of LevĂ¤tĂ¤â„˘ CBD dosables in the United States and Europe.
By identifying such information and statements in this manner, Halo is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from those expressed or implied by such information and statements. In addition, in connection with the forward-looking information and forward-looking statements contained in this press release, Halo has made certain assumptions. Although Halo believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and Halo does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to Halo or persons acting on its behalf is expressly qualified in its entirety by this notice.